Mukesh Patekar

Mukesh Patekar

Auto-generated profile, based on publicly available information

Mukesh Patekar

Department of Medical Oncology BLK MAX Superspeciality Hospital New Delhi India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2022 in IEEE Transactions on Plasma Science
Verified
Journal Article
Closed access
ATAjinkya M. Trimukhe
Ajinkya M. Trimukhe
KPK. N. Pandiyaraj
K. N. Pandiyaraj
MPMukesh Patekar
Mukesh Patekar
VMVandana Miller
Vandana Miller
RDRajendra Deshmukh
Rajendra Deshmukh
Cancer is a devastating and life-threatening disease. It is the second leading cause of death worldwide after heart diseases. While science has significantly advanced to improve the treatment outcome and quality of life in cancer patients, there are still many issues with the current therapies, such as toxicity and the development of resistance to treatment. Among the novel tools to overcome these limitations is nonthermal plasma (NTP) and its treatment regimens. Recent progress in NTP devices with ion temperatures close to room temperature demonstrated significant potential in cancer therapy. NTP devices provide a unique combination of reactive oxygen species (ROS), reactive nitrogen species (RNS), photons, and electric fields that exhibit desirable properties of triggering cell death pathways, selectively for cancer cells. While in principle NTP is nonnecrotic and gentle to the tissue, but reactive oxygen and nitrogen species (RONS)-triggered tumor cell death exhibited to have pro-immunogenic properties. Many in vitro and in vivo experiments have demonstrated antitumor effects of direct NTP, synergistic applications of NTP with anticancer drugs/treatments, and plasma-conditioned medium (PCM) applications against a variety of cancer cells. The latest results and findings in this field are the subject of this review along with a brief lay-reader-explanation of cancer and immunology. In this review, initially, we give an overview of the literature that deals with studies on the use of NTP for cancer treatment. Subsequently, we present typical results from that literature to illustrate the advances of NTP in oncology. Finally, we discuss some challenges and future scopes offered by NTP for cancer treatment.

31 May 2026 in View
Verified
Journal Article
Open access
ATA. M. Trimukhe
A. M. Trimukhe
Satish RojekarSatish Rojekar
Satish Rojekar
AGAmol Dilip Gholap
Amol Dilip Gholap
KPK. Navaneetha Pandiyaraj
K. Navaneetha Pandiyaraj
MPMukesh Patekar
Mukesh Patekar
Kalim DeshmukhKalim Deshmukh
Kalim Deshmukh
Bacterial resistance to antibiotic therapies, coupled with the propensity of microbes to develop highly recalcitrant biofilms on medical devices, which are primary cause of implant failures. These infections necessitate complex revision surgeries and contribute to morbidity and mortality rates in healthcare. Despite the limitations inherent in various targeted sterilization approaches, nonthermal plasma (NTP) has emerged as a highly potent and versatile technology for the decontamination of medical device surfaces. In our review, initially, we discussed comprehensively the implant surface physicochemical attributes that cause the attachment of bacteria, which advances to biofilms on the medical device surfaces. Key findings discuss various antimicrobial approaches, distinctly categorizing plasma interventions. Plasma surface modification (PSM) is highlighted for altering surface wettability and immobilizing antimicrobial agents. Furthermore, the review evaluates plasma‐activated liquids (PALs) for their role in delivering reactive species to complex geometries. In contrast, direct NTP approaches emphasize the immediate gaseous‐phase interaction of reactive oxygen and nitrogen species (RONS) with the device surface to achieve acute infection control. The review analyses the overall NTPs in vitro studies, mostly using plasma‐treated liquids, and in vivo by infiltration of ROS, generating oxidative stress and DNA leakage from the cell walls, as demonstrated efficiently against a broad range of bacteria. The review concludes with the challenges, such as standardization of plasma type and its process parameters.